New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financia... (luating ways in which we can work with c...)

HOME >> MEDICINE >> NEWS

New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes

Date:11/21/2008

luating ways in which we can work with community pharmacies to bring the benefits and solutions we have created in the TRCs to the patients they serve. We are also working with policymakers in Washington to share what we have learned in hopes that it can serve as a model contributing to the many health care reform efforts under consideration today."

About Medco

Medco Health Solutions, Inc. (NYSE: MHS) is the nation's leading pharmacy benefit manager based on its 2007 total net revenues of more than $44 billion. Medco's prescription drug benefit programs, covering approximately one-in-five Americans, are designed to drive down the cost of pharmacy health care for private and public employers, health plans, labor unions and government agencies of all sizes, for individuals served by the Medicare Part D Prescription Drug Program, and those served by Medco's specialty pharmacy segment, Accredo Health Group. Medco, the world's most advanced pharmacy(R), is positioned to serve the unique needs of patients with chronic and complex conditions through its Medco Therapeutic Resource Centers(R), including its enhanced diabetes pharmacy care practice through the Liberty acquisition. Medco is the highest-ranked independent pharmacy benefit manager on the 2008 Fortune 100 list. On the Net: http://www.medcohealth.com.

This press release contains "forward-looking statements" as that term is defined in the Private Securities Litigation Reform Act of 1995. These statements involve risks and uncertainties that may cause results to differ materially from those set forth in the statements. No forward-looking statement can be guaranteed, and actual results may differ materially from those projected. We undertake no obligation to publicly upda
'/>"/>

0

GOOD

Page: 1 2 3 4 5 6
Related medicine news :

1. New Study Data: JANUVIA™ (sitagliptin) Significantly Reduced Blood Sugar Levels and Was Not Associated with Hypoglycemia in Elderly Patients with Type 2 Diabetes
2. Communicating Clinical Trial Data: Timing Remains Key Challenge for Marketing Teams
3. Shining light on sciences dark data: New venture ensures a fuller scientific record
4. New Government Data: Mail-Service Pharmacies Grow, But Public Programs Lag Behind
5. Five Hospitals to Share Patient Data: ICW Connects Regional Medical Centers and University Facility
6. Clinical trial data: Safety/efficacy of concomitant formoterol fumarate/tiotropium treating COPD
7. Watson Announces the NDA for a 6-Month Formulation of TRELSTAR(R) Accepted for Filing by FDA for the Treatment of Advanced Prostate Cancer
8. Debiopharm Announces U.S. NDA Filing of Trelstar(R) 6-Month Formulation for Locally Advanced or Metastatic Prostate Cancer
9. Advanced lung cancer patients see improved, progression-free survival
10. Advanced Imaging Technologies to Limit Breast and GI Biopsy Procedures
11. Unilens Launches New C-VUE(R) Advanced(TM) Custom Toric Lens

Post Your Comments:

New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financia...(luating ways in which we can work with c...),Health